Tricor doesn’t reduce diabetics’ heart risk

A drug taken for decades by millions of people with type 2 diabetes to prevent heart attacks, strokes and deaths offered no benefit in a broad group of patients, a study released Sunday shows.

A 2010 study reports that Tricor (Fenofibrate) which has been taken by adult-onset diabetics in order to prevent heart attacks, strokes and deaths offers no benefit.  The product lowers triglycerides and raises good cholesterol, apparently lowering heart risk. But it failed to reduce  a combination of strokes, heart attacks  and deaths in patients with adult-onset diabetes.

Researchers: Henry Ginsberg, and associates, Columbia University.

Editor’s Note: Diabetic sufferers are at high risk of onset of diabetic retinopathy which can lead to permanent vision loss. Learn about information on nutrients (such as alpha lipoic acid, taurine, bilberry, lutein, omega-3 fatty acids) related to helping preserve vision for those with diabetes.